According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...
Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...
FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. have landed in the FDA’s crosshairs thanks to quality shortfalls, poor testing standards ...
From turning away inspectors to falsifying data and leaving "bare footprints" in production containers, two of the latest warning letters posted by the FDA read like an instruction manual on what not ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results